What is Microbot Medical's net sales royalty percentage?

Microbot Medical (MBOT) reported net sales royalty percentage of 3% in Q1 2026.

How has Microbot Medical's net sales royalty percentage changed year-over-year?

Microbot Medical's net sales royalty percentage decreased by 0.0% year-over-year, from 3% to 3%.

What does net sales royalty percentage mean?

Indicates the portion of net sales revenue that must be paid to third parties as a royalty for the use of licensed intellectual property or technology. This metric highlights the impact of external technology dependencies on the company's gross margins and long-term profitability.

Microbot Medical MBOT Net Sales Royalty Percentage

Net Sales Royalty Percentage at other companies

OS TherapiesOSTX

6%0.0pp

BalchemBCPC

$493K+7.6%

OS TherapiesOSTX

150%—

Ultragenyx PharmaceuticalRARE

30%—

Ondas, Inc. ONDS

3%0.0pp

SharkNinjaSN

$3.33M-30.5%

Other financials

Income statement

See full

Revenue$105.0K—

Gross profit$2.0K—

Operating income-$4.3M-43.0%

Net income-$3.7M-41.1%

EPS (diluted)-$0.05+37.5%

Balance sheet

See full

Cash & equivalents$3.7M+13.7%

Total debt$898.0K+551%

Total equity$74.1M+156%

Total assets$78.1M+153%

Cash flow

See full

Operating cash flow-$5.1M-75.8%

CapEx$108.0K+731%

Free cash flow-$5.2M-78.8%

Valuation

See full

Market cap$128.28M+36.1%

Enterprise value$125.53M+39.0%

P/S674.3×—

Profitability

See full

Operating margin25,292.9%—

Net margin-3,669.9%—

FCF margin-852.8%—

Returns & leverage

See full

Return on equity-27.6%-10.2pp

Debt / equity0×0.0×

Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept MBOT:NetSalesRoyaltyPercentage.

The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's net sales royalty percentage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Microbot Medical's net sales royalty percentage?: Microbot Medical (MBOT) reported net sales royalty percentage of 3% in Q1 2026.
How has Microbot Medical's net sales royalty percentage changed year-over-year?: Microbot Medical's net sales royalty percentage decreased by 0.0% year-over-year, from 3% to 3%.
What does net sales royalty percentage mean?: Indicates the portion of net sales revenue that must be paid to third parties as a royalty for the use of licensed intellectual property or technology. This metric highlights the impact of external technology dependencies on the company's gross margins and long-term profitability.